363
Views
0
CrossRef citations to date
0
Altmetric
Research Report

Gene Signature of Breast Cancer Cell Lines Treated with Lycopene

, , , , &
Pages 663-672 | Published online: 03 Aug 2006

Bibliography

  • Williams GM , WilliamsCL, WeisburgerJH: Diet and cancer prevention: the fiber first diet.Toxicol. Sci.52(2 Suppl.), 72–86 (1999).
  • Block G , PattersonB, SubarA: Fruit, vegetables, and cancer prevention: a review of the epidemiological evidence.Nutr. Cancer18(1), 1–29 (1992).
  • Ziegler RG : A review of epidemiologic evidence that carotenoids reduce the risk of cancer.J. Nutr.119(1), 116–122 (1989).
  • Comstock GW , BushTL, HelzlsouerK: Serum retinol, β-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites.Am. J. Epidemiol.135(2), 115–121 (1992).
  • Potischman N , McCullochCE, ByersT et al.: Breast cancer and dietary and plasma concentrations of carotenoids and vitamin A. Am. J. Clin. Nutr.52(5), 909–915 (1990).
  • Weisburger JH : Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids.Am. J. Clin. Nutr.53(1 Suppl.), 226S–237S (1991).
  • Di M ascio P, Kaiser S, Sies H: Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch. Biochem. Biophys.274(2), 532–538 (1989).
  • Levy J , BosinE, FeldmanB et al.: Lycopene is a more potent inhibitor of human cancer cell proliferation than either α-carotene or β-carotene. Nutr. Cancer24(3), 257–266 (1995).
  • Stahl W , J von Laar, Martin HD, Emmerich T, Sies H: Stimulation of gap junctional communication: comparison of acyclo-retinoic acid and lycopene. Arch. Biochem. Biophys.373(1), 271–274 (2000).
  • Chapman MS , VermaIM: Transcriptional activation by BRCA1.Nature382(6593), 678–679 (1996).
  • Monteiro AN , AugustA, HanafusaH: Evidence for a transcriptional activation function of BRCA1 C-terminal region.Proc. Natl Acad. Sci. USA93(24), 13595–13599 (1996).
  • Chalabi N , Le Corre L, Maurizis JC, Bignon YJ, Bernard-Gallon DJ: The effects of lycopene on the proliferation of human breast cells and BRCA1 and BRCA2 gene expression. Eur. J. Cancer40(11), 1768–1775 (2004).
  • Saeed AI , SharovV, WhiteJ et al.: TM4: a free, open-source system for microarray data management and analysis. Biotechniques.34(2), 374–378 (2003).
  • Tusher VG , TibshiraniR, ChuG: Significance analysis of microarrays applied to the ionizing radiation response.Proc. Natl Acad. Sci. USA98(9), 5116–5121 (2001).
  • Hosack DA , DennisG Jr, Sherman BT, Lane HC, Lempicki RA: Identifying biological themes within lists of genes with EASE. Genome Biol.4(10), R70 (2003).
  • Ohtsubo M , RobertsJM: Cyclin-dependent regulation of G1 in mammalian fibroblasts.Science259(5103), 1908–1912 (1993).
  • Ohtsubo M , TheodorasAM, SchumacherJ, RobertsJM, PaganoM: Human cyclin E, a nuclear protein essential for the G1-to-S phase transition.Mol. Cell Biol.15(5), 2612–2624 (1995).
  • Jin S , AntinoreMJ, LungFD et al.: The GADD45 inhibition of Cdc2 kinase correlates with GADD45-mediated growth suppression. J. Biol. Chem.275(22), 16602–16608 (2000).
  • Kastan MB , ZhanQ, el-DeiryWS et al.: A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell71(4), 587–597 (1992).
  • Sheikh MS , HollanderMC, FornanceAJ Jr: Role of Gadd45 in apoptosis. Biochem. Pharmacol.59(1), 43–45 (2000).
  • Tran H , BrunetA, GrenierJM et al.: DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein. Science296(5567), 530–534 (2002).
  • Harkin DP , BeanJM, MiklosD et al.: Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell.97(5), 575–586 (1999).
  • Jin S , ZhaoH, FanF et al.: BRCA1 activation of the GADD45 promoter. Oncogene19(35), 4050–4057 (2000).
  • Harper JW : Cyclin dependent kinase inhibitors.Cancer Surv.29, 91–107 (1997).
  • Somasundaram K , ZhangH, ZengYX et al.: Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature389(6647), 187–190 (1997).
  • Karas M , AmirH, FishmanD et al.: Lycopene interferes with cell cycle progression and insulin-like growth factor I signaling in mammary cancer cells. Nutr. Cancer36(1), 101–111 (2000).
  • Nahum A , HirschK, DanilenkoM et al.: Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Oncogene20(26), 3428–3436 (2001).
  • Marks JR , HuperG, VaughnJP et al.: BRCA1expression is not directly responsive to estrogen. Oncogene14(1), 115–121 (1997).
  • Fan S , WangJA, YuanRQ et al.: BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins. Oncogene16(23), 3069–3082 (1998).
  • Fan S , MaYX, WangC et al.: Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene20(1), 77–87 (2001).
  • Fan S , YuanR, MaYX, MengQ, GoldbergID, RosenEM: Mutant BRCA1 genes antagonize phenotype of wild-type BRCA1.Oncogene.20(57), 8215–8235 (2001).
  • Yan Y , HaasJP, KimM, SgagiasMK, CowanKH: BRCA1-induced apoptosis involves inactivation of ERK1/2 activities.J. Biol. Chem.277(36), 33422–33430 (2002).
  • Haupt Y , RowanS, ShaulianE, VousdenKH, OrenM: Induction of apoptosis in HeLa cells by trans-activation-deficient p53.Genes Dev.9(17), 2170–2183 (1995).
  • Rosen EM , FanS, PestellRG, GoldbergID: BRCA1 gene in breast cancer.J. Cell Physiol.196(1), 19–41 (2003).
  • Wang Y , CortezD, YazdiP, NeffN, Elledge SJ, Qin J: BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev.14(8), 927–939 (2000).
  • Hartman AR , FordJM: BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair.Nature Genet.32(1), 180–184 (2002).
  • Takimoto R , MacLachlanTK, DickerDT, NiitsuY, MoriT, el-DeiryWS: BRCA1 transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-irradiation.Cancer Biol. Ther.1(2), 177–186 (2002).
  • Wang Q , ZhangH, GuerretteS et al.: Adenosine nucleotide modulates the physical interaction between hMSH2 and BRCA1. Oncogene20(34), 4640–4649 (2001).
  • Pasupathy K , BhattacharyaRK: Damage to DNA and activity of nuclear DNA repair and replicative enzymes following N-nitrosodiethylamine treatment to rats.J. Biochem. Mol. Toxicol.14(5), 277–282 (2000).
  • Fitzgerald P , TengM, ChandraratnaRA, HeymanRA, AllegrettoEA: Retinoic acid receptor α expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.Cancer Res.57(13), 2642–2650 (1997).
  • Pasquali D , BellastellaA, ValenteA et al.: Retinoic acid receptors α, β and γ, and cellular retinol binding protein-I expression in breast fibrocystic disease and cancer. Eur. J. Endocrinol.137(4), 410–414 (1997).
  • Redgrave TG : Formation and metabolism of chylomicrons.Int. Rev. Physiol.28, 103–130 (1983).
  • Fuhrman B , JudithO, KeidarS, Ben-Yaish L, Kaplan M, Aviram M: Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL. Free Radic. Biol. Med.23(1), 34–46 (1997).
  • Parker RS : Carotenoids in human blood and tissues.J. Nutr.119(1), 101–104 (1989).
  • Romanchik JE , MorelDW, HarrisonEH: Distributions of carotenoids and α-tocopherol among lipoproteins do not change when human plasma is incubated in vitro.J. Nutr.125(10), 2610–2617 (1995).
  • Didier G , BrezellecP, RemyE, HenautA: GeneANOVA – gene expression analysis of variance.Bioinformatics13(3), 490–491 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.